The effort, called SepTech, will begin on Sept. 1 and run through August 2029, and it picks up from an earlier project called ECLIPSE.

NEW YORK – Four years into implementation of the federal No Surprises Act (NSA), claims for clinical lab testing comprise a substantial proportion of bills being disputed under the law. And in the ...

NEW YORK – Congress is taking another stab at establishing formal timelines for local coverage determination (LCD) reviews by Medicare Administrative Contractors (MACs). Last month, Rep. Neal Dunn, ...

NEW YORK — Proscia said on Thursday that its Concentriq AP-Dx digital pathology software has received 510(k) clearance from the US Food and Drug Administration for use with Leica Aperio GT 450 DX ...

ANAHEIM, Calif. — Point-of-care firm Kompass Diagnostics took first place in the Disruptive Technology Award Competition at the Association for Diagnostics & Laboratory Medicine's annual meeting here ...

NEW YORK – Based on data generated in the National Lung Screening Trial (NLST) cohort, cancer testing firm Mercy BioAnalytics believes its lung cancer early detection assay can identify cancers missed ...

NEW YORK – During a webcast presentation at the 44 th Annual JP Morgan Healthcare Conference in San Francisco on Monday, Qiagen CEO Theirry Bernard projected a near-term revival of lab equipment ...

NEW YORK – The Centers for Medicare & Medicaid Services issued a request for information Thursday seeking public input on potential updates to the Clinical Laboratory Improvement Amendments of 1988 ...

NEW YORK — Diagnostics developer BioAffinity said on Wednesday that it has priced a $3.2 million public stock offering. According to the San Antonio-based firm, it intends to sell 4 million shares of ...

NEW YORK – Alzheimer's diagnostic company Alzpath announced on Wednesday that it has signed a global licensing agreement with Abbott to develop blood-based tests for Alzheimer's disease. Financial and ...

NEW YORK – Waters said Wednesday that it has received US Food and Drug Administration 510(k) approval for its automated BD Bactec FXI Culture System. According to Waters, clinical study data shows ...

NEW YORK – Bio-Rad Laboratories has obtained the CE mark for next-generation versions of its Specialty Immunoassay Plus quality control reagents, the firm said Wednesday. The SPIA Plus quality ...